— Know what they know.
Not Investment Advice

LFWD NASDAQ

Lifeward Ltd.
1W: -16.3% 1M: -19.4% 3M: -33.0% YTD: -21.8% 1Y: -31.3% 3Y: -90.4% 5Y: -96.5%
$5.85
-0.11 (-1.85%)
 
Weekly Expected Move ±6.6%
$5 $5 $6 $6 $7
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 29 · $9.4M mcap · 2M float · 0.584% daily turnover · Short 42% of daily vol

Supply Chain Overview

14 relationships
13
As Filer
counterparties named
1
As Counterparty
mentioned by others
3
Rel. Types
2023-08-09
Earliest Filing
2026-03-25
Latest Filing
acquirer: 7 target: 5 partner: 1

Counterparties (Filed by LFWD)

13 relationships

Companies named in LFWD's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Lifeward Ltd. LFWD acquirer Parent company in the Share Purchase Agreement. 2026-03-25 View
Oramed Pharmaceuticals Inc. ORMP target Seller of shares in the Share Purchase Agreement. 2026-03-25 View
Oratech Pharma, Inc. — target Target company in the Share Purchase Agreement prior to assignment. 2026-03-25 View
Oratech Ltd. — acquirer Successor entity assigned the rights and obligations of the target company. 2026-03-25 View
Lifeward Ltd. LFWD acquirer Parent company entering into a Share Purchase Agreement 2026-01-13 View
Oratech Pharma, Inc. — acquirer Delaware corporation entering into a Share Purchase Agreement 2026-01-13 View
Oramed Pharmaceuticals Inc. ORMP target Delaware corporation being acquired in the Share Purchase Agreement 2026-01-13 View
ReWalk Robotics Ltd. RWLK acquirer Acquired AlterG for approximately $19 million in cash 2023-08-11 View
AlterG, Inc. — target Acquired by ReWalk Robotics Ltd. for its Anti-Gravity systems 2023-08-11 View
ReWalk Robotics, Inc. — acquirer Parent company acquiring AlterG, Inc. 2023-08-09 View
Atlas Merger Sub, Inc. — acquirer Wholly-owned subsidiary of ReWalk Robotics, Inc. used for the merger. 2023-08-09 View
AlterG, Inc. — target Target company being merged into Atlas Merger Sub, Inc. 2023-08-09 View
Shareholder Representative Services LLC — partner Securityholder Representative acting as agent for AlterG, Inc. stockholders. 2023-08-09 View

Mentioned As Counterparty

1 mentions

Other companies that named LFWD in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
ORMP ORAMED PHARMACEUTICALS INC. target Acquired all outstanding equity interests in Oratech from Oramed Pharmaceuticals Inc. in exchange for shares, warrants, 2026-01-14 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-01 Officer/Director Change View
2026-09-15 Other Events View
2026-09-08 Regulation FD; Exhibits View
2026-08-31 Officer/Director Change View
2026-08-20 Officer/Director Change View
2026-08-14 Earnings Release; Officer/Director Change; Exhibits View
2026-07-07 Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits Agreement View
2026-05-19 Other Events View
2026-05-15 Earnings Release View
2026-04-23 Officer/Director Change View
2026-03-31 Other Events View
2026-03-25 Acquisition/Disposition; Unregistered Equity Sales; Officer/Director Change; Exhibits Acquisition View
2026-03-13 Submission of Matters to a Vote of Security Holders View
2026-03-11 Other Events View
2026-03-02 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2026-02-27 Departure/Election of Directors; Appointment of Officers View
2026-02-25 Unregistered Sales of Equity Securities; Other Events View
2026-02-19 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation Agreement View
2026-02-09 Other Events View
2026-01-28 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms